Severe Esophageal Ulceration With Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Case Report.

求助中 20 由士多啤梨发布于 2026/8/28 10:39:36

DOI:10.21873/anticanres.18069
作者：Hiroki Bamba,?Satoshi Yamamoto,?Keita Higa,?Koichiro Kurokawa,?Sanji Kanaoka,?Kazuyoshi Nakamura
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Background/aim: The combination of enfortumab vedotin (EV) and pembrolizumab (P) has been recently established as the standard first-line treatment for advanced urothelial carcinoma. While t

应助信息

等您来应助

上传文件

1天前

Book学术机器人

2026/8/28 10:39:39 未找到该文献，机器人已退出，请等待人工下载

2026/8/28 10:39:36 Book学术AI机器人收到请求，开始寻找文献

2026/8/28 10:39:36 已向机器人发送请求

1天前

士多啤梨发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileySynthetic Studies Directed Toward the Proposed Structure for Heteroscyphic Acid A.